These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 4020945)

  • 21. Inhibitory effects of intravenous chloramphenicol sodium succinate on the disposition of phenylbutazone in horses.
    Gerken DF; Sams RA
    J Pharmacokinet Biopharm; 1985 Oct; 13(5):467-76. PubMed ID: 3834064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of phenylbutazone in two age groups of ponies: a preliminary study.
    Lees P; Maitho TE; Taylor JB
    Vet Rec; 1985 Mar; 116(9):229-32. PubMed ID: 4002593
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of phenylbutazone and oxyphenbutazone on basic drug detection in high performance thin layer chromatographic systems.
    Woods WE; Chay S; Houston T; Blake JW; Tobin T
    J Vet Pharmacol Ther; 1985 Jun; 8(2):181-9. PubMed ID: 2862290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantification of phenylbutazone in equine sera by use of high-performance liquid chromatography with a nonevaporative extraction technique.
    Peck KE; Ray AC; Manuel G; Rao MM; Foos J
    Am J Vet Res; 1996 Nov; 57(11):1522-4. PubMed ID: 8915422
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oxyphenbutazone and phenylbutazone determination in plasma and urine by GLC.
    Bruce RB; Maynard WR; Dunning LK
    J Pharm Sci; 1974 Mar; 63(3):446-8. PubMed ID: 4820382
    [No Abstract]   [Full Text] [Related]  

  • 26. Nonsteroidal anti-inflammatory agents and musculoskeletal injuries in Thoroughbred racehorses in Kentucky.
    Dirikolu L; Woods WE; Boyles J; Lehner AF; Harkins JD; Fisher M; Schaeffer DJ; Tobin T
    J Vet Pharmacol Ther; 2009 Jun; 32(3):271-9. PubMed ID: 19646092
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disposition and tolerance of suxibuzone in horses.
    Jaraiz MV; Rodriguez C; San Andres MD; Gonzalez F; San Andres MI
    Equine Vet J; 1999 Sep; 31(5):411-6. PubMed ID: 10505957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of urine pH on urine levels of oxyphenbutazone in racing horses.
    Houston T; Tobin T; Blake JW
    Drug Metab Dispos; 1983; 11(6):617-9. PubMed ID: 6140151
    [No Abstract]   [Full Text] [Related]  

  • 29. Influence of dietary portein on the disposition and metabolism of phenylbutazone in rats.
    Varma DR
    Can J Physiol Pharmacol; 1980 Mar; 58(3):231-6. PubMed ID: 7378926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of phenylbutazone and its metabolite oxyphenbutazone in miniature donkeys.
    Matthews NS; Peck KE; Taylor TS; Mealey KL
    Am J Vet Res; 2001 May; 62(5):673-5. PubMed ID: 11341383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of urine flow rate in mares.
    Gronwall R; Price G
    Am J Vet Res; 1985 May; 46(5):1107-10. PubMed ID: 4003886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The disposition of suxibuzone in the horse.
    Delbeke FT; Vynckier L; Debackere M
    J Vet Pharmacol Ther; 1993 Sep; 16(3):283-90. PubMed ID: 8230399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of phenylbutazone in horses producing acid urines.
    Moss MS; Haywood PE
    Vet Rec; 1973 Aug; 93(5):124-5. PubMed ID: 4763773
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacokinetics of phenylbutazone in neonatal foals.
    Wilcke JR; Crisman MV; Sams RA; Gerken DF
    Am J Vet Res; 1993 Dec; 54(12):2064-7. PubMed ID: 8116939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cortisol concentrations in blood and urine of horses.
    Ralston JM; Stenhouse AM; Stenhouse NS; Buck GJ; Lucks SF; Reynoldson JA; Bolton JR
    Aust Vet J; 1988 Jan; 65(1):1-5. PubMed ID: 2835031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-isotopic immunoassay drug tests in racing horses: a review of their application to pre- and post-race testing, drug quantitation, and human drug testing.
    Tobin T; Watt DS; Kwiatkowski S; Tai HH; Blake JW; McDonald J; Prange CA; Wie S
    Res Commun Chem Pathol Pharmacol; 1988 Dec; 62(3):371-95. PubMed ID: 3065859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenylbutazone blood and urine concentrations, pharmacokinetics, and effects on biomarkers of inflammation in horses following intravenous and oral administration of clinical doses.
    Knych HK; Arthur RM; McKemie DS; Seminoff K; Hamamoto-Hardman B; Kass PH
    Drug Test Anal; 2019 Jun; 11(6):792-803. PubMed ID: 30499176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of phenylbutazone in camels.
    Wasfi IA; Abdel Hadi AH; Zorob O; Osman M al-G ; Boni NS
    Am J Vet Res; 1997 Jun; 58(6):636-40. PubMed ID: 9185972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solid-phase extraction for the high-performance liquid chromatographic determination of indomethacin, suxibuzone, phenylbutazone and oxyphenbutazone in plasma, avoiding degradation of compounds.
    Caturla MC; Cusido E
    J Chromatogr; 1992 Oct; 581(1):101-7. PubMed ID: 1429991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Kinetics of anti-inflammatory drugs in serum and synovia of horses (author's transl)].
    Lehmann W; Wintzer HJ; Frey HH
    Dtsch Tierarztl Wochenschr; 1981 Jun; 88(6):218-20. PubMed ID: 7026207
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.